er dose, the particular second anti-neoplastic agent used, the amount of the second anti-neoplastic agent per dose, the dose schedule and the route of administration should be decided by the practitioner using methods known to those skilled in the art and will depend on the type of cancer, the severity of the cancer, the location of the cancer and other clinical factors such as the size, weight an